Integrated Profiling of Human Pancreatic Cancer Organoids Reveals Chromatin Accessibility Features Associated with Drug Sensitivity

The authors identified distinct transcription factors that distinguished molecular subtypes of pancreatic cancer, predicted numerous chromatin accessibility peaks associated with gene regulatory networks, discovered regulatory noncoding mutations with potential as cancer drivers, and revealed the chromatin accessibility signatures associated with drug sensitivity.